Who
Michael F. Brigham
Director
Company insider
Files Form 4 as: President & CEO, ImmuCell.
In numbers
- Trades disclosed
- 30
- Buys
- 5
- Sells
- 0
- Bought
- $74K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Mar 2006
- Last trade
- 20 Mar 2026
- Last filed
- 24 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $146K25,000 at $5.84 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code F | $146K24,052 at $6.07 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $146K25,000 at $5.84 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code F | $146K24,052 at $6.07 | filing |
| 31 Jan 2022filed 9 Feb 2022 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $8,1501,000 at $8.15 | filing |
| 28 Dec 2018filed 28 Dec 2018 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $81K47,500 at $1.70 | filing |
| 28 Dec 2018filed 28 Dec 2018 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $81K47,500 at $1.70 | filing |
| 8 Jan 2018filed 10 Jan 2018 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $156K20,000 at $7.80 | filing |
| 17 Mar 2017filed 21 Mar 2017 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $5,2501,000 at $5.25 | filing |
| 17 Mar 2017filed 21 Mar 2017 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $5,2501,000 at $5.25 | filing |
| 10 Feb 2017filed 14 Feb 2017 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $146K25,000 at $5.84 | filing |
| 13 Dec 2013filed 16 Dec 2013 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 13 Dec 2013filed 16 Dec 2013 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $3,1001,000 at $3.10 | filing |
| 16 Nov 2011filed 17 Nov 2011 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 16 Nov 2011filed 17 Nov 2011 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $3,195618 at $5.17 | filing |
| 16 Nov 2011filed 17 Nov 2011 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code M | $3,2001,000 at $3.20 | filing |
| 10 Dec 2010filed 10 Dec 2010 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code X | —1,000 at $0.00 | filing |
| 10 Dec 2010filed 10 Dec 2010 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $2,0001,000 at $2.00 | filing |
News
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales ResultsICCC · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Michael F. Brigham; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.